220 related articles for article (PubMed ID: 30551868)
21. Racial and Socioeconomic Disparities in the Treatments and Outcomes of Pancreatic Cancer Among Different Treatment Facility Types.
Zhu F; Wang H; Ashamalla H
Pancreas; 2020; 49(10):1355-1363. PubMed ID: 33122525
[TBL] [Abstract][Full Text] [Related]
22. Decompositions of the Contribution of Treatment Disparities to Survival Disparities in Stage I-II Pancreatic Adenocarcinoma.
Swords DS; Scaife CL
Ann Surg Oncol; 2021 Jun; 28(6):3157-3168. PubMed ID: 33145705
[TBL] [Abstract][Full Text] [Related]
23. Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma - A population-based cohort study.
Labori KJ; Katz MH; Tzeng CW; Bjørnbeth BA; Cvancarova M; Edwin B; Kure EH; Eide TJ; Dueland S; Buanes T; Gladhaug IP
Acta Oncol; 2016; 55(3):265-77. PubMed ID: 26213211
[TBL] [Abstract][Full Text] [Related]
24. Socioeconomic Factors Affect Presentation Stage and Survival in Sinonasal Squamous Cell Carcinoma.
Jafari A; Shen SA; Qualliotine JR; Lehmann AE; Humphreys IM; Abuzeid WM; Bergmark RW; Gray ST
Laryngoscope; 2021 Nov; 131(11):2421-2428. PubMed ID: 33844294
[TBL] [Abstract][Full Text] [Related]
25. Treatment and survival vary by race/ethnicity in patients with anaplastic thyroid cancer.
Roche AM; Fedewa SA; Shi LL; Chen AY
Cancer; 2018 Apr; 124(8):1780-1790. PubMed ID: 29409119
[TBL] [Abstract][Full Text] [Related]
26. Neoadjuvant therapy versus upfront surgery for resected pancreatic adenocarcinoma: A nationwide propensity score matched analysis.
de Geus SW; Eskander MF; Bliss LA; Kasumova GG; Ng SC; Callery MP; Tseng JF
Surgery; 2017 Mar; 161(3):592-601. PubMed ID: 28341441
[TBL] [Abstract][Full Text] [Related]
27. Association of Socioeconomic Status and Race/Ethnicity With Treatment and Survival in Patients With Medullary Thyroid Cancer.
Roche AM; Fedewa SA; Chen AY
JAMA Otolaryngol Head Neck Surg; 2016 Aug; 142(8):763-71. PubMed ID: 27254481
[TBL] [Abstract][Full Text] [Related]
28. The impact of socioeconomic status on survival in stage III colon cancer patients: A retrospective cohort study using the SEER census-tract dataset.
Dhahri A; Kaplan J; Naqvi SMH; Brownstein NC; Ntiri SO; Imanirad I; Felder SI; Dineen SP; Sanchez J; Dessureault S; Carballido E; Powers BD
Cancer Med; 2021 Aug; 10(16):5643-5652. PubMed ID: 34197047
[TBL] [Abstract][Full Text] [Related]
29. Outcomes of multimodality therapies for patients with stage II or III rectal cancer in California, 1994-2009.
Cho MM; Morgan JW; Knutsen R; Oda K; Shavlik D; Knutsen S; Kazanjian K
Dis Colon Rectum; 2013 Dec; 56(12):1357-65. PubMed ID: 24201389
[TBL] [Abstract][Full Text] [Related]
30. Healthcare disparities in outcomes of patients with resectable pancreatic cancer.
Moaven O; Richman JS; Reddy S; Wang T; Heslin MJ; Contreras CM
Am J Surg; 2019 Apr; 217(4):725-731. PubMed ID: 30583797
[TBL] [Abstract][Full Text] [Related]
31. Sociodemographic Disparities in the Receipt of Adjuvant Chemotherapy Among Patients With Resected Stage I-III Pancreatic Adenocarcinoma.
Sanford NN; Aguilera TA; Folkert MR; Ahn C; Mahal BA; Zeh H; Beg MS; Mansour J; Sher DJ
J Natl Compr Canc Netw; 2019 Nov; 17(11):1292-1300. PubMed ID: 31693987
[TBL] [Abstract][Full Text] [Related]
32. Association of County-level Upward Economic Mobility with Stage at Diagnosis and Receipt of Treatment Among Patients Diagnosed with Pancreatic Adenocarcinoma.
Dalmacy D; Paro A; Hyer JM; Obeng-Gyasi S; Pawlik TM
Ann Surg; 2023 Apr; 277(4):e872-e877. PubMed ID: 35129521
[TBL] [Abstract][Full Text] [Related]
33. Increased neutrophil-to-lymphocyte ratio after neoadjuvant therapy is associated with worse survival after resection of borderline resectable pancreatic ductal adenocarcinoma.
Glazer ES; Rashid OM; Pimiento JM; Hodul PJ; Malafa MP
Surgery; 2016 Nov; 160(5):1288-1293. PubMed ID: 27450715
[TBL] [Abstract][Full Text] [Related]
34. Health disparities and impact on outcomes in children with primary central nervous system solid tumors.
Austin MT; Hamilton E; Zebda D; Nguyen H; Eberth JM; Chang Y; Elting LS; Sandberg DI
J Neurosurg Pediatr; 2016 Nov; 18(5):585-593. PubMed ID: 27540957
[TBL] [Abstract][Full Text] [Related]
35. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ
Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289
[TBL] [Abstract][Full Text] [Related]
36. Differences in Treatment and Outcome of Pancreatic Adenocarcinoma Stage I and II in the EURECCA Pancreas Consortium.
Groen JV; Sibinga Mulder BG; van Eycken E; Valerianova Z; Borras JM; van der Geest LGM; Capretti G; Schlesinger-Raab A; Primic-Zakelj M; Ryzhov A; van de Velde CJH; Bonsing BA; Bastiaannet E; Mieog JSD
Ann Surg Oncol; 2018 Nov; 25(12):3492-3501. PubMed ID: 30151560
[TBL] [Abstract][Full Text] [Related]
37. Ethnic and racial disparities of pancreatic adenocarcinoma in Florida.
Fagenson AM; Grossi SM; Musgrove K; Solomon N; de la Vega PR; Castro G; Pitt HA; Varella M; Zavallos J; Acuna J
HPB (Oxford); 2020 May; 22(5):735-743. PubMed ID: 31601507
[TBL] [Abstract][Full Text] [Related]
38. Are patients of low socioeconomic status receiving suboptimal management for pancreatic adenocarcinoma?
Cheung MC; Yang R; Byrne MM; Solorzano CC; Nakeeb A; Koniaris LG
Cancer; 2010 Feb; 116(3):723-33. PubMed ID: 19998350
[TBL] [Abstract][Full Text] [Related]
39. Socioeconomic Disparities in Pancreas Cancer Resection and Survival in the Veterans Health Administration.
Del Valle JP; Fillmore NR; Molina G; Fairweather M; Wang J; Clancy TE; Ashley SW; Urman RD; Whang EE; Gold JS
Ann Surg Oncol; 2022 May; 29(5):3194-3202. PubMed ID: 35006509
[TBL] [Abstract][Full Text] [Related]
40. Health Disparities in Presentation, Treatment, Genomic Testing, and Outcomes of Pancreatic Cancer in Hispanic and Non-Hispanic Patients.
Halder R; Veeravelli S; Cheng C; Estrada-Mendizabal RJ; Recio-Boiles A
J Racial Ethn Health Disparities; 2023 Dec; 10(6):3131-3139. PubMed ID: 37071331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
